Company · CIK 2022416
Silexion Therapeutics Corp
| CIK | 2022416 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | E9 |
| Business address | Israel |
| Listed | SLXN (Nasdaq), SLXNW (Nasdaq) |
| First annual or quarterly report | 2024-08-29 |
Offerings
10 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298137 | 2026-08-07 | 2026-08-13 | 4 | |
| 333-296739 | 2026-06-12 | 2026-06-18 | 2 | |
| 333-282932 | 2024-10-31 | 2026-05-11 | 7 | |
| 333-290074 | 2025-09-05 | 2026-05-11 | 4 | |
| 333-291210 | 2025-10-31 | 2025-10-31 | 1 | |
| 333-290544 | 2025-09-26 | 2025-09-30 | 2 | |
| 333-289860 | 2025-08-26 | 2025-09-04 | 2 | |
| 333-282017 | 2024-09-10 | 2025-05-29 | 3 | |
| 333-282556 | 2024-10-09 | 2025-05-01 | 3 | |
| 333-284873 | 2025-02-12 | 2025-04-01 | 3 |
Filings
34| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-13 | 424B4Final prospectus | 333-298137 | 0001178913-26-004116 |
| 2026-08-11 | EFFECTDeclared effective | 333-298137 | 9999999995-26-002627 |
| 2026-08-10 | S-1/AAmendment | 333-298137 | 0001178913-26-004003 |
| 2026-08-07 | S-1Registration filed | 333-298137 | 0001178913-26-003961 |
| 2026-06-18 | EFFECTDeclared effective | 333-296739 | 9999999995-26-002070 |
| 2026-06-12 | S-3Shelf registered | 333-296739 | 0001178913-26-003174 |
| 2026-05-11 | EFFECTDeclared effective | 333-290074 | 9999999995-26-001566 |
| 2026-05-11 | EFFECTDeclared effective | 333-282932 | 9999999995-26-001565 |
| 2026-03-17 | DRSDraft made public | 377-09146 | 0001178913-26-000955 |
| 2025-10-31 | S-3Shelf registered | 333-291210 | 0001178913-25-003631 |
| 2025-09-30 | EFFECTDeclared effective | 333-290544 | 9999999995-25-003257 |
| 2025-09-26 | S-3Shelf registered | 333-290544 | 0001178913-25-003388 |
| 2025-09-12 | 424B4Final prospectus | 333-290074 | 0001178913-25-003306 |
| 2025-09-11 | EFFECTDeclared effective | 333-290074 | 9999999995-25-002937 |
| 2025-09-05 | S-1Registration filed | 333-290074 | 0001178913-25-003260 |
| 2025-09-04 | EFFECTDeclared effective | 333-289860 | 9999999995-25-002838 |
| 2025-08-26 | S-1Registration filed | 333-289860 | 0001178913-25-003107 |
| 2025-05-29 | EFFECTDeclared effective | 333-282017 | 9999999995-25-001764 |
| 2025-05-01 | EFFECTDeclared effective | 333-282556 | 9999999995-25-001335 |
| 2025-04-25 | EFFECTDeclared effective | 333-282932 | 9999999995-25-001247 |
| 2025-04-23 | DRSDraft made public | 377-07931 | 0001178913-25-001391 |
| 2025-04-01 | EFFECTDeclared effective | 333-284873 | 9999999995-25-000918 |
| 2025-03-27 | S-1/AAmendment | 333-284873 | 0001178913-25-001087 |
| 2025-02-12 | S-1Registration filed | 333-284873 | 0001178913-25-000443 |
| 2025-01-17 | 424B4Final prospectus | 333-282932 | 0001178913-25-000141 |
| 2025-01-15 | EFFECTDeclared effective | 333-282932 | 9999999995-25-000111 |
| 2025-01-14 | S-1/AAmendment | 333-282932 | 0001178913-25-000110 |
| 2025-01-14 | S-1/AAmendment | 333-282932 | 0001178913-25-000100 |
| 2024-10-31 | S-1Registration filed | 333-282932 | 0001178913-24-003417 |
| 2024-10-16 | EFFECTDeclared effective | 333-282556 | 9999999995-24-003201 |
| 2024-10-09 | S-1Registration filed | 333-282556 | 0001178913-24-003246 |
| 2024-09-17 | EFFECTDeclared effective | 333-282017 | 9999999995-24-002873 |
| 2024-09-10 | S-1Registration filed | 333-282017 | 0001213900-24-077039 |
| 2024-07-16 | EFFECTDeclared effective | 333-279281 | 9999999995-24-002178 |